OSTEOARTHRITIS THERAPEUTIC MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-157620 | Health Care
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Osteoarthritis Therapeutic Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL OSTEOARTHRITIS THERAPEUTIC MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL OSTEOARTHRITIS THERAPEUTIC MARKET
7.1 GLOBAL OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Sanofi (France)
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Horizon Therapeutics (Ireland)
16.3 Johnson & Johnson (United States)
16.4 GlaxoSmithKline Plc (United Kingdom)
16.5 Bayer AG (Germany)
16.6 Abbott (United States)
16.7 Pfizer (United States)
16.8 Eli Lilly (United States)
16.9 Anika Therapeutics (United States)
16.10 Novartis (Switzerland)
16.11 Bioventus (United States)
16.12 Zimmer Biomet Holdings, Inc.(United States)
16.13 Flexion Therapeutics (United States)
16.14 Fidia Farmaceutici s.p.a. (Italy)
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By DrugViscosupplementation Agents
Nonsteroidal Anti-inflammatory Drugs
Analgesics
Corticosteroids
By Route of Administration
Parenteral
Topical
Oral
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Anatomy
Knee
Hip
Hand
Small Joints (Foot & Ankle and Wrist )
By Purchase Mode
Prescription Drug
Over-the-counter Drug
Companies
Sanofi (France)
Horizon Therapeutics (Ireland)
Johnson & Johnson (United States)
GlaxoSmithKline Plc (United Kingdom)
Bayer AG (Germany)
Abbott (United States)
Pfizer (United States)
Eli Lilly (United States)
Anika Therapeutics (United States)
Novartis (Switzerland)
Bioventus (United States)
Zimmer Biomet Holdings, Inc.(United States)
Flexion Therapeutics (United States)
Fidia Farmaceutici s.p.a. (Italy)
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.